Oxford Nanopore Technologies plc (ONTTF)
USD 1.57
(-0.61%)
USD 1.57
(-0.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 133.21 Million GBP | 2.21% |
| 2022 | 130.33 Million GBP | -5.48% |
| 2021 | 137.89 Million GBP | 44.73% |
| 2020 | 95.27 Million GBP | 72.58% |
| 2019 | 55.2 Million GBP | 70.95% |
| 2018 | 32.29 Million GBP | 25.55% |
| 2017 | 25.72 Million GBP | 87.69% |
| 2016 | 13.7 Million GBP | 65.34% |
| 2015 | 8.28 Million GBP | 93.62% |
| 2014 | 4.28 Million GBP | 38.19% |
| 2013 | 3.09 Million GBP | 54.29% |
| 2012 | 2 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 144.07 Million GBP | 0.0% |
| 2023 Q4 | 133.21 Million GBP | 0.0% |
| 2023 FY | 133.21 Million GBP | 2.21% |
| 2023 Q1 | 117.61 Million GBP | -9.76% |
| 2023 Q2 | 117.61 Million GBP | 0.0% |
| 2023 Q3 | 133.21 Million GBP | 13.26% |
| 2022 Q4 | 130.33 Million GBP | 0.0% |
| 2022 FY | 130.33 Million GBP | -5.48% |
| 2022 Q3 | 130.33 Million GBP | 12.15% |
| 2022 Q2 | 116.21 Million GBP | 0.0% |
| 2022 Q1 | 116.21 Million GBP | -15.72% |
| 2021 Q4 | 137.89 Million GBP | 0.0% |
| 2021 FY | 137.89 Million GBP | 44.73% |
| 2021 Q1 | 86.62 Million GBP | -9.08% |
| 2021 Q2 | 86.62 Million GBP | 0.0% |
| 2021 Q3 | 137.89 Million GBP | 59.18% |
| 2020 Q4 | 95.27 Million GBP | 0.0% |
| 2020 FY | 95.27 Million GBP | 72.58% |
| 2020 Q3 | 95.27 Million GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2019 FY | 55.2 Million GBP | 70.95% |
| 2018 FY | 32.29 Million GBP | 25.55% |
| 2017 FY | 25.72 Million GBP | 87.69% |
| 2016 FY | 13.7 Million GBP | 65.34% |
| 2015 FY | 8.28 Million GBP | 93.62% |
| 2014 FY | 4.28 Million GBP | 38.19% |
| 2013 FY | 3.09 Million GBP | 54.29% |
| 2012 FY | 2 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Qrons Inc. | 1.48 Million USD | -8848.065% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -125.728% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -16370.325% |
| Adynxx, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -66135.904% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -165.023% |
| BioStem Technologies, Inc. | 15.9 Million USD | -737.559% |
| CSL Limited | 18.62 Billion USD | 99.285% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -1307.269% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -83.813% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -77.804% |
| Regen BioPharma, Inc. | 5.45 Million USD | -2340.828% |
| Skye Bioscience, Inc. | 14.07 Million USD | -846.623% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -297937.856% |
| Rebus Holdings, Inc. | 5.24 Million USD | -2441.225% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -485486.702% |
| Neon Bloom, Inc. | 1.22 Million USD | -10763.61% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -149.903% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -1290.218% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -31498.935% |
| SQZ Biotechnologies Company | 50.03 Million USD | -166.214% |
| Intellipharmaceutics International Inc. | 12 Million USD | -1009.281% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -3358.747% |
| Mesoblast Limited | 188.44 Million USD | 29.31% |
| Marizyme, Inc. | 26.67 Million USD | -399.372% |
| Genus plc | 485 Million USD | 72.534% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -2179.987% |
| Pharming Group N.V. | 244.07 Million USD | 45.422% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -6526.984% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -5193.865% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -3405.553% |
| ContraFect Corporation | 32.53 Million USD | -309.489% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -6623.387% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -3380.231% |
| IMV Inc. | 37.93 Million USD | -251.176% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -1030.997% |
| MultiCell Technologies, Inc. | 1617.67 USD | -8234645.035% |
| ONE Bio Corp. | 27.49 Million USD | -384.477% |
| Accustem Sciences Inc. | 1.07 Million USD | -12243.049% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -72.069% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -6198.187% |
| Q BioMed Inc. | 8.13 Million USD | -1537.92% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -60.621% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -2488.614% |
| Biomind Labs Inc. | 1.49 Million USD | -8788.959% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -12.204% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -1373.215% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -623.838% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -9190.371% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -93647.845% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -2218.398% |
| GB Sciences, Inc. | 5.41 Million USD | -2358.876% |
| Alpha Cognition Inc. | 7.16 Million USD | -1759.249% |
| HST Global, Inc. | 593.59 Thousand USD | -22341.471% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -10479.077% |
| Halberd Corporation | 728.71 Thousand USD | -18180.16% |
| Enzolytics Inc. | 365.26 Million USD | 63.531% |
| Agentix Corp. | 2.51 Million USD | -5206.038% |
| Resverlogix Corp. | 67.39 Million USD | -97.654% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -15782.427% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 70.062% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -7671.937% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -438.313% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -1019.129% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -3534.517% |
| AVAX Technologies, Inc. | 3.99 Million USD | -3235.491% |
| Zenith Capital Corp. | 27.56 Thousand USD | -483091.266% |
| Genscript Biotech Corporation | 1.32 Billion USD | 89.953% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -55717.627% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -3467.222% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -19465.856% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -4812.56% |
| Kadimastem Ltd | 3.5 Million USD | -3700.743% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -198933.304% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -28566.083% |
| LadRx Corporation | 2.2 Million USD | -5953.593% |
| Cell Source, Inc. | 15.8 Million USD | -742.749% |
| Regen BioPharma, Inc. | 5.45 Million USD | -2340.828% |
| NovAccess Global Inc. | 7.86 Million USD | -1594.639% |
| Affymax, Inc. | 8.87 Million USD | -1401.646% |
| Itoco Inc. | 1.65 Million USD | -7958.006% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -6393.141% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -2102.199% |
| Mobile Lads Corp. | 1.31 Million USD | -10041.706% |
| CytoDyn Inc. | 127.89 Million USD | -4.157% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -318594.227% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -8404.402% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -1106.044% |
| SYBLEU INC | 681.41 Thousand USD | -19449.231% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -2083.105% |
| International Stem Cell Corporation | 5.27 Million USD | -2424.37% |
| Bioxytran, Inc. | 3.24 Million USD | -3999.431% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -21186.207% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -2785.15% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -224.937% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -498.298% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -6477.064% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -2331.745% |
| Neutra Corp. | 973.52 Thousand USD | -13583.311% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -359.111% |
| PureTech Health plc | 125.58 Million USD | -6.074% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -3445.557% |
| IXICO plc | 1.9 Million USD | -6910.028% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -548.892% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -28.926% |
| CSL Limited | 18.62 Billion USD | 99.285% |
| Cellectis S.A. | 249.36 Million USD | 46.581% |